Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Ventas Inc. Common Stock (VTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Ventas Inc. Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Ventas Inc. Common Stock trades at $82.53 (market cap $41.06B). The key difference: Ventas Inc. Common Stock is far larger — about 24× Nuvation Bio Inc. Class A Common Stock's market cap, and Ventas Inc. Common Stock pays a 2.6% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Ventas Inc. Common Stock for 0 Days on average.
| NUVB | VTR | |
|---|---|---|
Market Cap | $1.71B | $41.06B |
Volume | 5,448,712 | 4,174,820 |
Sector | Health | Real Estate |
52-Week High | $9.54 | $100.53 |
52-Week Low | $3.41 | $67.45 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.30B | $53.78B |
Dividend Yield | — | 2.6% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Ventas Inc. Common Stock
Ventas is a real estate investment trust focused on healthcare properties. Its portfolio includes senior housing, medical office buildings, and research-related facilities.
Read more on VTR →
